You are here

Article info

Article menu

This article has a correction. Please see:

Basic tumor immunology
Original research
Gallic acid induces T-helper-1-like Treg cells and strengthens immune checkpoint blockade efficacy

Authors

  • Biaolong Deng Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Respiratory and Critical Care Medicine of Ruijin Hospital, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Biaolong Yang Department of Medical Oncology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China PubMed articlesGoogle scholar articles
  • Jieqiong Chen Shanghai Affinity Biopharmaceutical Co., Ltd, Shanghai, China PubMed articlesGoogle scholar articles
  • Shuaiwei Wang Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Respiratory and Critical Care Medicine of Ruijin Hospital, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Weiqi Zhang Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Respiratory and Critical Care Medicine of Ruijin Hospital, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Yixian Guo Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China PubMed articlesGoogle scholar articles
  • Yichao Han Department of Thoracic Surgery, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Hecheng Li Department of Thoracic Surgery, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Yongjun Dang Fudan University School of Basic Medical Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Yaqin Yuan Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Respiratory and Critical Care Medicine of Ruijin Hospital, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Xueyu Dai Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Respiratory and Critical Care Medicine of Ruijin Hospital, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Yuansheng Zang Department of Medical Oncology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China PubMed articlesGoogle scholar articles
  • Yangyang Li Unit of Immune and Metabolic Regulation, School of Life Science and Technology, ShanghaiTech University, Shanghai, China PubMed articlesGoogle scholar articles
  • Bin Li Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Respiratory and Critical Care Medicine of Ruijin Hospital, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Thoracic Surgery, Clinical Translational Research Center, Shanghai Pulmonary Hospital, Shanghai, ChinaDepartment of Integrated TCM and Western Medicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, ChinaInstitute of Arthritis Research, Guanghua Integrative Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaShenzhen Key Laboratory of Immunity and Inflammatory Diseases, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles

Citation

Deng B, Yang B, Chen J, et al
Gallic acid induces T-helper-1-like Treg cells and strengthens immune checkpoint blockade efficacy
Journal for ImmunoTherapy of Cancer 2022;10:e004037. doi: 10.1136/jitc-2021-004037
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.